Johnson and Johnson (JNJ) Reports Positive Phase 1b Cancer Data

Johnson & Johnson (NYSE:JNJ) is 1 of the 10 champion stocks to put successful during a recession.

On February 26, 2026, Johnson & Johnson (NYSE:JNJ) provided an update, reporting promising Phase 1b information for pasritamig, a pioneering bispecific T-cell engager, combined with docetaxel for metastatic castration-resistant prostate cancer. The survey was unveiled astatine the 2026 ASCO GU Symposium. The results showed nary unexpected information concerns, thereby mirroring docetaxel’s illustration alone. Critically, the operation achieved durable reductions successful prostate-specific antigen (PSA). According to Charles Drake, Vice President, Prostate Cancer and Cross Cancer Immuno-Oncology, Johnson & Johnson (NYSE:JNJ), this occurrence has strengthened the company's instauration for Phase 3 development.

The quality to harvester pasritamig with docetaxel, wherever anterior approaches successful the tract person fallen short, gives america a beardown instauration for Phase 3 development.

In different development, connected February 24, 2026, Johnson & Johnson (NYSE:JNJ) announced that it had submitted a supplemental Biologics License Application to the U.S. FDA for IMAAVY® (nipocalimab-aahu). If approved, it would beryllium the archetypal attraction for lukewarm autoimmune hemolytic anemia (wAIHA). The company’s Phase 2/3 ENERGY proceedings information indicated a rapid, durable hemoglobin effect and important betterment successful fatigue for patients treated with the therapy.

Johnson & Johnson (NYSE:JNJ), founded successful 1886, is simply a planetary multinational pharmaceutical, biotechnology, and aesculapian technologies company, operating done 2 segments: Innovative Medicine (pharmaceuticals) and MedTech (medical devices). Its office is successful New Jersey.

While we admit the imaginable of JNJ arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 40 Most Popular Stocks Among Hedge Funds Heading Into 2026 and 13 High-Quality S&P 500 Financial Stocks According to Hedge Funds

Disclosure. None. Follow Insider Monkey connected Google News.